Here, we found that symptom screening, CRP (using a 5 mg/L cut-point), and symptoms + CRP met or exceeded the 90% sensitivity target established by the WHO for an effective TB screening test among ART-naïve males and females. The gene discussed is CRP; the disease is tuberculosis.